TRIB — Trinity Biotech Share News
0.000.00%
Last trade - 00:00- $5.11m
- $137.96m
- $43.79m
Trinity Biotech PLC expected to post earnings of 7 cents a share - Earnings Preview
Trinity Biotech PLC expected to post earnings of 7 cents a share - Earnings Preview
Trinity Biotech PLC expected to post earnings of 7 cents a share - Earnings Preview
Brief: Trinity Biotech Announces The World Health Organisation Approval Of Trinscreen™ Hiv
Brief: Trinity Biotech Announces Q3 2021 Results
Trinity Biotech PLC expected to post earnings of 7 cents a share - Earnings Preview
Brief: Trinity Biotech Announces The Submission Of Trinscreen Hiv To The World Health Organisation For Approval
Trinity Biotech: Rises after COVID-19 test gets EU nod
Brief: Trinity Biotech Announces CE Mark Of Its Covid-19 IgG ELISA Antibody Test
Brief: Trinity Biotech PLC Appoints John Gillard as CFO
Trinity Biotech: Rises on Q3 revenue beat
Trinity Biotech PLC expected to post earnings of $10.00 a share - Earnings Preview
Brief: Trinity Biotech Announces EUA Submission For Covid-19 Elisa Antibody Test
Brief: Trinity Biotech Subsidiary, Primus Corporation Receives FDA Warning Letter
Trinity Biotech: Down as co's unit receives FDA warning for Hemoglobin product
Brief: Trinity Biotech PLC Files For Mixed Shelf Of Up To $200 Million
Brief: Trinity Biotech Reports Q1 Earnings Per Share Of $0.053
Brief: Trinity Biotech PLC Reports Qtrly Diluted Earnings Per ADR Of $0.09
U.S. STOCKS ON THE MOVE-Achillion Pharma, Citigroup, Johnson & Johnson, Workday